This study provides insight into the link between the PI3K/Akt signaling pathway and potential chemotherapy resistance in PPP and provides mechanistic evidence supporting chaetocin as a possible therapeutic strategy to eliminate chemotherapy resistance in NSCLC. Here, AKT1 is linked to non-small cell lung carcinoma.